首页 > 最新文献

Journal of the Saudi Heart Association最新文献

英文 中文
A Vanishing Cardiac Mass. 消失的心脏肿块。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-12-27 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1287
Moayad M Alqurashi, Ahmed Alsaileek, Thamer H Alenazi, Basel M Alhaijani, Ahmed Aljizeeri

The prevalence of extrapulmonary tuberculosis (TB) is very common in the Middle East; however, myocardial involvement is among the most infrequent manifestations of extrapulmonary TB. We present a young adult who was incidentally found to have a large right atrial tuberculoma, diagnosed by non-invasive cardiac imaging and effectively treated with standard first-line anti-TB treatment, steroids, and anticoagulation. This case is a classical presentation of nodular myocardial involvement of TB, highlighting advantages of advanced imaging, e.g., cardiac magnetic resonance (CMR) and multidisciplinary treatment.

肺外结核(TB)的流行在中东非常普遍;然而,心肌受累是肺外结核最罕见的表现之一。我们报告一位年轻的成年人偶然发现有一个大的右心房结核瘤,通过无创心脏成像诊断,并有效地接受了标准的一线抗结核治疗,类固醇和抗凝治疗。该病例是结核结节性心肌受累的典型表现,突出了先进成像的优势,例如心脏磁共振(CMR)和多学科治疗。
{"title":"A Vanishing Cardiac Mass.","authors":"Moayad M Alqurashi,&nbsp;Ahmed Alsaileek,&nbsp;Thamer H Alenazi,&nbsp;Basel M Alhaijani,&nbsp;Ahmed Aljizeeri","doi":"10.37616/2212-5043.1287","DOIUrl":"https://doi.org/10.37616/2212-5043.1287","url":null,"abstract":"<p><p>The prevalence of extrapulmonary tuberculosis (TB) is very common in the Middle East; however, myocardial involvement is among the most infrequent manifestations of extrapulmonary TB. We present a young adult who was incidentally found to have a large right atrial tuberculoma, diagnosed by non-invasive cardiac imaging and effectively treated with standard first-line anti-TB treatment, steroids, and anticoagulation. This case is a classical presentation of nodular myocardial involvement of TB, highlighting advantages of advanced imaging, e.g., cardiac magnetic resonance (CMR) and multidisciplinary treatment.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"347-352"},"PeriodicalIF":0.8,"publicationDate":"2021-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/87/sha-347-352.PMC8765037.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39866062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of Routine 2D Echocardiography to Estimate Patent Ductus Arteriosus Type and Dimension and Predict Device Selection for Successful PDA Occlusion. 常规二维超声心动图评估动脉导管未闭类型和尺寸的准确性以及预测成功阻断PDA的器械选择。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-11-29 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1284
Mohammed Omar Galal, Zaheer Ahmad, Arif Hussain, Masroor Sharfi, Yahia El Mahdi, Fayzah El Khattab, Amjad Alkouatli, Riad Abou Zahr

Background: Assessment of the shape and dimensions of PDA is usually done angiographically and in the majority of cases need arterial access. Our aim was to evaluate the value of routine 2 D echocardiography (ECHO) in predicting type, dimensions of PDA and to anticipate device size to be used during the intervention.

Material and methods: The charts of all patients who underwent transcatheter closure of PDA between January 2015 and December 2020 were reviewed. Their pre-procedure ECHO and catheterization details at the time of device closure were analyzed.

Results: Total of 139 patients were reviewed and 8 were excluded because of lack of adequate echocardiographic or angiographic images. The mean age and weight of the study population were 2.6 ± 2.5 years (range 0.2-14 years) and 11.2 ± 7.8 kg (range: 1.5-57 kg), respectively. There was no statistically significant difference in PDA narrowest diameter (p = 0.99) and predicted device type (p = 0.54) between Echo and angiography. Echo slightly overestimated PDA length (p = 0.01) and aortic ampulla dimension (p = 0.047), while morphology of PDA was correctly identified in the majority of cases (82%).

Conclusions: Pre-procedure echocardiography correlates well with angiographically obtained measurements and hence can be used to estimate PDA diameter, shape and guide device decide selection. Routine echocardiography can be used successfully to plan the intervention and in some cases to guide transcatheter closure.

背景:评估PDA的形状和尺寸通常是通过血管造影完成的,在大多数情况下需要动脉通路。我们的目的是评估常规二维超声心动图(ECHO)在预测PDA类型、尺寸和预测干预期间使用的设备尺寸方面的价值。材料与方法:回顾2015年1月至2020年12月所有经导管封堵PDA患者的病历。分析他们的术前ECHO和设备关闭时的导管细节。结果:139例患者被复查,8例因超声心动图或血管造影图像不足而被排除。研究人群的平均年龄和体重分别为2.6±2.5岁(0.2-14岁)和11.2±7.8 kg (1.5-57 kg)。超声与血管造影在PDA最窄直径(p = 0.99)和预测器械类型(p = 0.54)上差异无统计学意义。超声略微高估了PDA的长度(p = 0.01)和腹主动脉尺寸(p = 0.047),但绝大多数病例(82%)正确识别了PDA的形态。结论:术前超声心动图与血管造影测量结果具有良好的相关性,因此可用于估计PDA的直径,形状和引导装置的选择。常规超声心动图可以成功地用于计划干预,并在某些情况下指导经导管闭合。
{"title":"Accuracy of Routine 2D Echocardiography to Estimate Patent Ductus Arteriosus Type and Dimension and Predict Device Selection for Successful PDA Occlusion.","authors":"Mohammed Omar Galal,&nbsp;Zaheer Ahmad,&nbsp;Arif Hussain,&nbsp;Masroor Sharfi,&nbsp;Yahia El Mahdi,&nbsp;Fayzah El Khattab,&nbsp;Amjad Alkouatli,&nbsp;Riad Abou Zahr","doi":"10.37616/2212-5043.1284","DOIUrl":"https://doi.org/10.37616/2212-5043.1284","url":null,"abstract":"<p><strong>Background: </strong>Assessment of the shape and dimensions of PDA is usually done angiographically and in the majority of cases need arterial access. Our aim was to evaluate the value of routine 2 D echocardiography (ECHO) in predicting type, dimensions of PDA and to anticipate device size to be used during the intervention.</p><p><strong>Material and methods: </strong>The charts of all patients who underwent transcatheter closure of PDA between January 2015 and December 2020 were reviewed. Their pre-procedure ECHO and catheterization details at the time of device closure were analyzed.</p><p><strong>Results: </strong>Total of 139 patients were reviewed and 8 were excluded because of lack of adequate echocardiographic or angiographic images. The mean age and weight of the study population were 2.6 ± 2.5 years (range 0.2-14 years) and 11.2 ± 7.8 kg (range: 1.5-57 kg), respectively. There was no statistically significant difference in PDA narrowest diameter (p = 0.99) and predicted device type (p = 0.54) between Echo and angiography. Echo slightly overestimated PDA length (p = 0.01) and aortic ampulla dimension (p = 0.047), while morphology of PDA was correctly identified in the majority of cases (82%).</p><p><strong>Conclusions: </strong>Pre-procedure echocardiography correlates well with angiographically obtained measurements and hence can be used to estimate PDA diameter, shape and guide device decide selection. Routine echocardiography can be used successfully to plan the intervention and in some cases to guide transcatheter closure.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"339-346"},"PeriodicalIF":0.8,"publicationDate":"2021-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/46/sha-339-346.PMC8754450.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39862135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Zwolle Risk Score for Safety Assessment of Same-day Discharge after Primary Percutaneous Coronary Intervention. 用于原发性经皮冠状动脉介入术后当天出院安全性评估的 Zwolle 风险评分。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-11-12 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1283
Jehangir Ali Shah, Bashir Ahmed Solangi, Mahesh Kumar Batra, Kamran Ahmed Khan, Ghazanfar Ali Shah, Gulzar Ali, Mehwish Zehra, Muhammad Hassan, Muhammad Zubair, Musa Karim

Objectives: The Zwolle risk score (ZRS) has been considered to be a useful tool for the systematic evaluation of patients for early discharge after primary percutaneous coronary intervention (PCI). Therefore, aim of this study was to evaluate the clinical utility of ZRS for the same-day discharge strategy after primary PCI at a tertiary care cardiac center of Karachi, Pakistan.

Methods: This study was conducted at a tertiary care cardiac center between August 2019 and July 2020. Patients discharged within 24 h (same-day) of the primary PCI procedure were included. Patients were stratified as high- and low-risk based on ZRS score; low-risk (≤3) and high-risk (≥4). All patients were followed during 30-days post-procedure period for major adverse cardiac events (MACE).

Results: Out of 487 patients, 83.2% (405) were male and mean age was 54.6 ± 10.87 years. Mean ZRS was 2.34 ± 1.64 with 16.0% (78) patients in high-risk (≥4) group. 30-days MACE rate was observed to be 5.3% (26) with significantly higher rate among high-risk patients as compared to low-risk patients 12.8% (10) vs. 3.9% (16); p = 0.004 respectively with OR of 3.61 [1.57-8.29]. The area under the curve (AUC) of ZRS for prediction of 30-day MACE was 0.67 [95% CI: 0.58-0.77], ZRS ≥4 had sensitivity of 38.5% and specificity of 85.2% with AUC of 0.62 [95% CI: 0.50-0.74] for prediction of 30-day MACE.

Conclusion: ZRS showed moderate discriminating potential in identifying patients with high-risk of MACE at 30-day after same-day discharge after primary PCI.

目的:兹沃勒风险评分(ZRS)被认为是系统评估患者是否适合在经皮冠状动脉介入治疗(PCI)后提前出院的有效工具。因此,本研究的目的是评估 ZRS 在巴基斯坦卡拉奇一家三级医疗心脏中心初级 PCI 术后当天出院策略中的临床实用性:本研究于 2019 年 8 月至 2020 年 7 月期间在一家三级医疗心脏中心进行。研究纳入了在初级 PCI 术后 24 小时内(当天)出院的患者。根据 ZRS 评分将患者分为高危和低危;低危(≤3)和高危(≥4)。所有患者均在术后30天内接受随访,以了解是否发生了重大心脏不良事件(MACE):在487名患者中,83.2%(405人)为男性,平均年龄为(54.6±10.87)岁。平均 ZRS 为 2.34 ± 1.64,高风险(≥4)组患者占 16.0%(78 人)。观察发现,30 天内 MACE 发生率为 5.3% (26),高危患者的发生率明显高于低危患者,分别为 12.8% (10) vs. 3.9% (16);P = 0.004,OR 为 3.61 [1.57-8.29] 。ZRS预测30天MACE的曲线下面积(AUC)为0.67[95% CI:0.58-0.77],ZRS≥4预测30天MACE的敏感性为38.5%,特异性为85.2%,AUC为0.62[95% CI:0.50-0.74]:结论:ZRS在识别初级PCI术后当日出院后30天MACE高风险患者方面显示出适度的鉴别潜力。
{"title":"Zwolle Risk Score for Safety Assessment of Same-day Discharge after Primary Percutaneous Coronary Intervention.","authors":"Jehangir Ali Shah, Bashir Ahmed Solangi, Mahesh Kumar Batra, Kamran Ahmed Khan, Ghazanfar Ali Shah, Gulzar Ali, Mehwish Zehra, Muhammad Hassan, Muhammad Zubair, Musa Karim","doi":"10.37616/2212-5043.1283","DOIUrl":"10.37616/2212-5043.1283","url":null,"abstract":"<p><strong>Objectives: </strong>The Zwolle risk score (ZRS) has been considered to be a useful tool for the systematic evaluation of patients for early discharge after primary percutaneous coronary intervention (PCI). Therefore, aim of this study was to evaluate the clinical utility of ZRS for the same-day discharge strategy after primary PCI at a tertiary care cardiac center of Karachi, Pakistan.</p><p><strong>Methods: </strong>This study was conducted at a tertiary care cardiac center between August 2019 and July 2020. Patients discharged within 24 h (same-day) of the primary PCI procedure were included. Patients were stratified as high- and low-risk based on ZRS score; low-risk (≤3) and high-risk (≥4). All patients were followed during 30-days post-procedure period for major adverse cardiac events (MACE).</p><p><strong>Results: </strong>Out of 487 patients, 83.2% (405) were male and mean age was 54.6 ± 10.87 years. Mean ZRS was 2.34 ± 1.64 with 16.0% (78) patients in high-risk (≥4) group. 30-days MACE rate was observed to be 5.3% (26) with significantly higher rate among high-risk patients as compared to low-risk patients 12.8% (10) vs. 3.9% (16); p = 0.004 respectively with OR of 3.61 [1.57-8.29]. The area under the curve (AUC) of ZRS for prediction of 30-day MACE was 0.67 [95% CI: 0.58-0.77], ZRS ≥4 had sensitivity of 38.5% and specificity of 85.2% with AUC of 0.62 [95% CI: 0.50-0.74] for prediction of 30-day MACE.</p><p><strong>Conclusion: </strong>ZRS showed moderate discriminating potential in identifying patients with high-risk of MACE at 30-day after same-day discharge after primary PCI.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"332-338"},"PeriodicalIF":0.8,"publicationDate":"2021-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/d1/sha-34-4-332.PMC8754437.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39862134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angioplasty of Anomalous Coronaries Arising from the Opposite Sinus with an Interarterial Course, is it Safe? 采用动脉间路径对来自对侧窦的异常冠状动脉进行血管成形术,安全吗?
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-11-12 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1280
Rania Hammami, Imtinene Ben Mrad, Amine Bahloul, Salma Charfeddine, Rym Gribaa, Houssem Thabet, Emna Allouche, Aymen Ben Abdessalem, Majed Hassine, Leila Abid, Samir Kammoun, Hassen Ibn Hadj Amor

Background: The coronary artery with an interarterial course CAIAC is the most threatening coronary anomaly, especially if it concerns the left coronary. Percutaneous coronary intervention PCI is scarcely described given its low prevalence and lack of long-term outcome data. Therefore, we assessed through this case series the feasibility and safety of PCI in this population.

Methods: This is an observational multicentric study including patients with CAIAC arising from the opposite sinus of Valsalva. The primary endpoints were immediate angiographic success and target lesion revascularization.

Results: During the period of the study, we performed 27235 PCI in six Cath labs, 26 procedures concerning abnormal coronaries including 12 with CAIAC. The median age was 57 years extremes: 43-78 with male predominance 1:11. Anomalous coronary artery was Right coronary artery RCA in eight patients, Left main LM in three patients, and left anterior descending LAD in one patient. The stenosis was located in all cases in proximal segments beyond the inter-arterial course proximal LAD, the superior genius of the RCA, or the proximal segment of mid-RCA. Five patients showed slit-like ostium and all have an angle take-off <45° on CT scan. After a median follow-up of 24 months, four subjects presented target lesion revascularization TLR, all were initially treated with either a bare-metal stent or with balloons.

Conclusions: PCI of patients with CAIAC is feasible and appears safe. The operator should carefully analyze the angiogram before PCI to choose the appropriate guiding catheter and should be acquainted with the different techniques for improving backup.

背景:冠状动脉动脉间病变(CAIAC)是最具威胁性的冠状动脉异常,尤其是涉及左冠状动脉时。由于经皮冠状动脉介入治疗(PCI)的发病率较低,且缺乏长期疗效数据,因此很少有人对其进行描述。因此,我们通过本系列病例评估了PCI在这一人群中的可行性和安全性:这是一项多中心观察性研究,研究对象包括瓦尔萨尔瓦对侧窦发生 CAIAC 的患者。主要终点是即时血管造影成功率和靶病变血运重建率:研究期间,我们在 6 个心电图室进行了 27235 例 PCI,其中 26 例涉及异常冠状动脉,包括 12 例 CAIAC。中位年龄为 57 岁,极端年龄为 43-78 岁:43-78岁,男性占1:11。8 名患者的异常冠状动脉为右冠状动脉 RCA,3 名患者的异常冠状动脉为左主 LM,1 名患者的异常冠状动脉为左前降 LAD。所有病例的狭窄部位均位于动脉间径近端 LAD、RCA 上段或中段 RCA 近端。五例患者的动脉管腔呈狭缝状,且均有角度起飞:对 CAIAC 患者进行 PCI 是可行且安全的。操作者在进行 PCI 前应仔细分析血管造影,选择合适的引导导管,并熟悉不同的技术以改善后备情况。
{"title":"Angioplasty of Anomalous Coronaries Arising from the Opposite Sinus with an Interarterial Course, is it Safe?","authors":"Rania Hammami, Imtinene Ben Mrad, Amine Bahloul, Salma Charfeddine, Rym Gribaa, Houssem Thabet, Emna Allouche, Aymen Ben Abdessalem, Majed Hassine, Leila Abid, Samir Kammoun, Hassen Ibn Hadj Amor","doi":"10.37616/2212-5043.1280","DOIUrl":"10.37616/2212-5043.1280","url":null,"abstract":"<p><strong>Background: </strong>The coronary artery with an interarterial course CAIAC is the most threatening coronary anomaly, especially if it concerns the left coronary. Percutaneous coronary intervention PCI is scarcely described given its low prevalence and lack of long-term outcome data. Therefore, we assessed through this case series the feasibility and safety of PCI in this population.</p><p><strong>Methods: </strong>This is an observational multicentric study including patients with CAIAC arising from the opposite sinus of Valsalva. The primary endpoints were immediate angiographic success and target lesion revascularization.</p><p><strong>Results: </strong>During the period of the study, we performed 27235 PCI in six Cath labs, 26 procedures concerning abnormal coronaries including 12 with CAIAC. The median age was 57 years extremes: 43-78 with male predominance 1:11. Anomalous coronary artery was Right coronary artery RCA in eight patients, Left main LM in three patients, and left anterior descending LAD in one patient. The stenosis was located in all cases in proximal segments beyond the inter-arterial course proximal LAD, the superior genius of the RCA, or the proximal segment of mid-RCA. Five patients showed slit-like ostium and all have an angle take-off <45° on CT scan. After a median follow-up of 24 months, four subjects presented target lesion revascularization TLR, all were initially treated with either a bare-metal stent or with balloons.</p><p><strong>Conclusions: </strong>PCI of patients with CAIAC is feasible and appears safe. The operator should carefully analyze the angiogram before PCI to choose the appropriate guiding catheter and should be acquainted with the different techniques for improving backup.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"296-305"},"PeriodicalIF":0.7,"publicationDate":"2021-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/6a/sha-33-4-296.PMC8754440.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stent or Shunt, What Could be Better for Children with Duct Dependent Pulmonary Circulation? 导管依赖性肺循环患儿支架或分流术,哪种治疗效果更好?
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-29 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1274
Ghassan A Shaath, Abdulraouf Mz Jijeh, Mohammed Fararjeh, Mohammad Allugmani, Fahad Alhabshan, Mansour B Almutairi, Ahmed Alomrani, Omar Tamimi

Background: Systemic to pulmonary shunt (Shunt) is offered for children with duct dependent pulmonary circulation to augment pulmonary flow. Recently patent ductus arteriosus (PDA) stent (Stent) is widely used as an alternative method. We aimed to compare post intervention outcomes in children underwent either procedure.

Methods: Infants under 3 months who had an initial palliation by Shunt or Stent were retrospectively reviewed between 2008 and 2016, then followed till the second intervention or 1 year whichever earlier.

Results: 187 patients (110 Shunt and 77 Stent) were included. Initial weight and pulmonary artery (PA) branches size were similar between the groups. Shunt patients had more shock preoperatively and required more emergency intervention. Stent group showed less ICU stay 4 (1-8) vs 13 (7-23) days, p < 0.0001 and less positive pressure ventilation days 1 (0-2) vs 5.5 (3-11), p < 0.0001. However, Stent group had more symptomatic arterial and deep venous thromboses. In Stent patients the branch PAs growth was better and more homogeneous. At follow-up, no difference between groups regarding cumulative readmission days to hospital, hemoglobin levels and the weight percentile for age. Mortality was not different with a tendency to be higher in the Shunt group (13%) compared to the Stent group (5%), p 0.1.

Conclusions: The implantation of PDA stent in patients with duct dependent pulmonary circulation results in a smoother ICU course and a shorter hospital stay, with higher risk of vascular injury. Shunt and Stent procedures have a good outcome for PA growth, somatic growth and survival.

背景:系统到肺分流(分流)是提供给儿童导管依赖肺循环增加肺流量。近年来,动脉导管未闭(PDA)支架(stent)作为一种替代方法被广泛应用。我们的目的是比较接受两种手术的儿童的干预后结果。方法:回顾性分析2008年至2016年期间通过分流器或支架进行初始缓解的3个月以下婴儿,然后随访至第二次干预或1年,以较早者为准。结果:共纳入187例患者(分流110例,支架77例)。各组的初始体重和肺动脉(PA)分支大小相似。分流术患者术前休克较多,需要较多的紧急干预。支架组ICU住院时间4天(1 ~ 8天)比13天(7 ~ 23天)少,p < 0.0001;正压通气1天(0 ~ 2天)比5.5天(3 ~ 11天)少,p < 0.0001。然而,支架组有更多的症状性动脉和深静脉血栓形成。在支架患者中,分支PAs生长更好且更均匀。在随访中,两组在累计再入院天数、血红蛋白水平和年龄的体重百分位数方面没有差异。与支架组(5%)相比,分流组(13%)的死亡率有更高的趋势,p = 0.1。结论:导管依赖型肺循环患者行PDA支架置入术,ICU病程较平稳,住院时间较短,血管损伤风险较高。分流和支架手术对PA生长、体生长和存活有良好的效果。
{"title":"Stent or Shunt, What Could be Better for Children with Duct Dependent Pulmonary Circulation?","authors":"Ghassan A Shaath,&nbsp;Abdulraouf Mz Jijeh,&nbsp;Mohammed Fararjeh,&nbsp;Mohammad Allugmani,&nbsp;Fahad Alhabshan,&nbsp;Mansour B Almutairi,&nbsp;Ahmed Alomrani,&nbsp;Omar Tamimi","doi":"10.37616/2212-5043.1274","DOIUrl":"https://doi.org/10.37616/2212-5043.1274","url":null,"abstract":"<p><strong>Background: </strong>Systemic to pulmonary shunt (Shunt) is offered for children with duct dependent pulmonary circulation to augment pulmonary flow. Recently patent ductus arteriosus (PDA) stent (Stent) is widely used as an alternative method. We aimed to compare post intervention outcomes in children underwent either procedure.</p><p><strong>Methods: </strong>Infants under 3 months who had an initial palliation by Shunt or Stent were retrospectively reviewed between 2008 and 2016, then followed till the second intervention or 1 year whichever earlier.</p><p><strong>Results: </strong>187 patients (110 Shunt and 77 Stent) were included. Initial weight and pulmonary artery (PA) branches size were similar between the groups. Shunt patients had more shock preoperatively and required more emergency intervention. Stent group showed less ICU stay 4 (1-8) vs 13 (7-23) days, <i>p</i> < 0.0001 and less positive pressure ventilation days 1 (0-2) vs 5.5 (3-11), <i>p</i> < 0.0001. However, Stent group had more symptomatic arterial and deep venous thromboses. In Stent patients the branch PAs growth was better and more homogeneous. At follow-up, no difference between groups regarding cumulative readmission days to hospital, hemoglobin levels and the weight percentile for age. Mortality was not different with a tendency to be higher in the Shunt group (13%) compared to the Stent group (5%), <i>p</i> 0.1.</p><p><strong>Conclusions: </strong>The implantation of PDA stent in patients with duct dependent pulmonary circulation results in a smoother ICU course and a shorter hospital stay, with higher risk of vascular injury. Shunt and Stent procedures have a good outcome for PA growth, somatic growth and survival.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"306-312"},"PeriodicalIF":0.8,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/17/69/sha-33-4-306.PMC8754443.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of Safety and Efficacy of Novel Sirolimus-Eluting Stent Incorporating Properties of Drug Coating Balloon Among Real World Patients Focusing Younger Population (<35 years). 结合药物包衣球囊特性的新型西罗莫司洗脱支架在以年龄<35岁的真实患者中的安全性和有效性研究
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-29 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1279
Santosh Kumar Sinha, Umeshwar Pandey, Mahmodullah Razi, Awadesh Kumar Sharma, Puneet Aggarwal, Mohit Sachan, Praveen Shukla, Ramesh Thakur

Objective: Aim of study was to evaluate safety and efficacy of abluminal Mitigator DES + Sirolimus Eluting Stent (Envision Scientific, Surat, India) incorporating novel technology of fusion coating of bioresorbable polymer on both abluminal surface of stent and exposed parts of balloon among real world patients specially focusing younger patients (<35 years).

Method: 1293 patients received Mitigator DES + at LPS Institute of Cardiology, Kanpur, India. Primary outcome was target lesion failure (TLF)- composite of cardiovascular death, target vessel myocardial infarction (TVMI), and target lesion revascularization (TLR) and secondary end points including peri-procedural device failure (failure of stent delivery, change of stent, stent fracture), target vessel failure (TVF), and patient oriented composite end point (POCE)-composite of all deaths, MI, and revascularization and stent thrombosis (ST) at 1-year follow-up.

Result: Younger population comprised of 374 (29%) patients. Various indications of interventions were STEMI (n = 614; 47.4%), NSTEMI (n = 416; 32.2%), UA (n = 161; 12.5%), and CCS (n = 102; 7.9%). TLF at 1 year in young and overall population were 3.4% and 3.5% respectively which was driven by TVMI and TLR in 1.3% and 1.1% patients respectively. POCE was observed in 9.5% in each group mainly contributed by any revascularization (3.9%). Device failure was significantly lower in young group than overall population (1.3% vs. 2.2%; p = 0.04) which was mainly driven by stent delivery (1.1%) and edge dissection (0.5%). Definite and probable ST was 1.3% and 1.7% respectively which was not significant. Young patients showed insignificantly lower TLF, TVF, ST and POCE and significantly lower device failure (1.3% vs. 2.6%; p = 0.04) when compared to patients >35 years. On multivariate regression analysis, complex lesion, in-stent restenosis, failure of stent delivery and edge dissection were independent predictors of events or device success rate.

Conclusion: Mitigator DES+™ is safe among real world patients, including young population.

目的:研究采用新型生物可吸收聚合物在支架和球囊暴露部位的腔面融合涂层技术的消化道Mitigator DES +西罗莫司洗脱支架(Envision Scientific, Surat, India)在现实患者中的安全性和有效性,特别是针对年轻患者(方法:1293例在印度坎普尔LPS心脏病研究所接受Mitigator DES +的患者)。主要终点是靶病变失败(TLF)——心血管死亡、靶血管心肌梗死(TVMI)和靶病变血运重建术(TLR)的复合终点;次要终点包括术中器械失败(支架输送失败、支架更换、支架断裂)、靶血管衰竭(TVF),以及患者导向的复合终点(POCE)——1年随访时所有死亡、心肌梗死、血管重建术和支架血栓形成(ST)的复合终点。结果:年轻人群374例(29%)。各种干预指征包括STEMI (n = 614;47.4%), NSTEMI (n = 416;32.2%), UA (n = 161;12.5%), CCS (n = 102;7.9%)。年轻人和总体人群1年TLF分别为3.4%和3.5%,其中TVMI和TLR分别为1.3%和1.1%。POCE发生率为9.5%,主要由血运重建术引起(3.9%)。年轻组的器械失败率明显低于整体人群(1.3% vs. 2.2%;P = 0.04),主要由支架放置(1.1%)和边缘剥离(0.5%)驱动。确定ST和可能ST分别为1.3%和1.7%,差异不显著。年轻患者的TLF、TVF、ST和POCE均无显著降低,设备失效显著降低(1.3% vs. 2.6%;P = 0.04),与>35岁的患者相比。在多元回归分析中,复杂病变、支架内再狭窄、支架输送失败和边缘剥离是事件或装置成功率的独立预测因素。结论:缓解剂DES+™在现实世界患者中是安全的,包括年轻人群。
{"title":"Study of Safety and Efficacy of Novel Sirolimus-Eluting Stent Incorporating Properties of Drug Coating Balloon Among Real World Patients Focusing Younger Population (<35 years).","authors":"Santosh Kumar Sinha,&nbsp;Umeshwar Pandey,&nbsp;Mahmodullah Razi,&nbsp;Awadesh Kumar Sharma,&nbsp;Puneet Aggarwal,&nbsp;Mohit Sachan,&nbsp;Praveen Shukla,&nbsp;Ramesh Thakur","doi":"10.37616/2212-5043.1279","DOIUrl":"https://doi.org/10.37616/2212-5043.1279","url":null,"abstract":"<p><strong>Objective: </strong>Aim of study was to evaluate safety and efficacy of abluminal Mitigator DES + Sirolimus Eluting Stent (Envision Scientific, Surat, India) incorporating novel technology of fusion coating of bioresorbable polymer on both abluminal surface of stent and exposed parts of balloon among real world patients specially focusing younger patients (<35 years).</p><p><strong>Method: </strong>1293 patients received Mitigator DES + at LPS Institute of Cardiology, Kanpur, India. Primary outcome was target lesion failure (TLF)- composite of cardiovascular death, target vessel myocardial infarction (TVMI), and target lesion revascularization (TLR) and secondary end points including peri-procedural device failure (failure of stent delivery, change of stent, stent fracture), target vessel failure (TVF), and patient oriented composite end point (POCE)-composite of all deaths, MI, and revascularization and stent thrombosis (ST) at 1-year follow-up.</p><p><strong>Result: </strong>Younger population comprised of 374 (29%) patients. Various indications of interventions were STEMI (n = 614; 47.4%), NSTEMI (n = 416; 32.2%), UA (n = 161; 12.5%), and CCS (n = 102; 7.9%). TLF at 1 year in young and overall population were 3.4% and 3.5% respectively which was driven by TVMI and TLR in 1.3% and 1.1% patients respectively. POCE was observed in 9.5% in each group mainly contributed by any revascularization (3.9%). Device failure was significantly lower in young group than overall population (1.3% vs. 2.2%; p = 0.04) which was mainly driven by stent delivery (1.1%) and edge dissection (0.5%). Definite and probable ST was 1.3% and 1.7% respectively which was not significant. Young patients showed insignificantly lower TLF, TVF, ST and POCE and significantly lower device failure (1.3% vs. 2.6%; p = 0.04) when compared to patients >35 years. On multivariate regression analysis, complex lesion, in-stent restenosis, failure of stent delivery and edge dissection were independent predictors of events or device success rate.</p><p><strong>Conclusion: </strong>Mitigator DES+™ is safe among real world patients, including young population.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"321-331"},"PeriodicalIF":0.8,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/b8/sha-33-4-321.PMC8754438.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39862133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Multiple Migrated Superior Vena Cava Stents With Cardiac Injury - A Stepwise Open Cardiotomy Strategy to Mitigate Potential Fatality. 心脏损伤多发上腔静脉支架移位-逐步开心术减轻潜在病死率的策略。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-29 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1281
Fayaz Mohammed Khazi, Samer Badr Eddin Alhashimi, Motaz Yousef Majthoob, Ayman Saleh, Ayman Al-Sibaie, Obaid Aljassim

Iatrogenic injuries with migrated interventional stents can sometimes be life-threatening. The interventional retrieval management is generally the treatment of choice, as surgical procedures carry a high mortality risk with only a few cases reported. We report a patient with two stents migrated into the right atrium from superior vena cava resulting in cardiac perforation. She was successfully treated using pericardiocentesis followed by surgical intervention with rapid post-operative resolution of symptoms. The technique presented here substantiates the steps for a safe and effective removal of these multiple displaced stents with minimal postprocedural complications.

迁移性介入支架的医源性损伤有时可能危及生命。由于外科手术具有较高的死亡率,只有少数病例报道,因此介入回收管理通常是治疗的选择。我们报告一个病人的两个支架从上腔静脉迁移到右心房导致心脏穿孔。她成功地通过心包穿刺术治疗,随后进行手术干预,术后症状迅速缓解。本文介绍的技术证实了安全有效地去除这些多移位支架的步骤,并将术后并发症降到最低。
{"title":"Multiple Migrated Superior Vena Cava Stents With Cardiac Injury - A Stepwise Open Cardiotomy Strategy to Mitigate Potential Fatality.","authors":"Fayaz Mohammed Khazi,&nbsp;Samer Badr Eddin Alhashimi,&nbsp;Motaz Yousef Majthoob,&nbsp;Ayman Saleh,&nbsp;Ayman Al-Sibaie,&nbsp;Obaid Aljassim","doi":"10.37616/2212-5043.1281","DOIUrl":"https://doi.org/10.37616/2212-5043.1281","url":null,"abstract":"<p><p>Iatrogenic injuries with migrated interventional stents can sometimes be life-threatening. The interventional retrieval management is generally the treatment of choice, as surgical procedures carry a high mortality risk with only a few cases reported. We report a patient with two stents migrated into the right atrium from superior vena cava resulting in cardiac perforation. She was successfully treated using pericardiocentesis followed by surgical intervention with rapid post-operative resolution of symptoms. The technique presented here substantiates the steps for a safe and effective removal of these multiple displaced stents with minimal postprocedural complications.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"317-320"},"PeriodicalIF":0.8,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/5d/sha-34-4-317.PMC8754445.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnostic Accuracy of Dobutamine Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Patients. 多巴酚丁胺应激超声心动图检测同种异体心脏移植患者血管病变的诊断准确性。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1265
Mohammed Mahmoodurrahman, Josef Marek, Hamzah Ruxshan Juhardeen, Talal Al Otaibi, Vera Maria Cury Salemi, Najmeddine Echahidi, Jehad Al Buraiki, Bahaa M Fadel, Dania Mohty

Objective: Cardiac allograft vasculopathy is one of the leading causes of late graft failure and subsequent death in orthotopic heart transplant. Although invasive coronary angiography is the gold standard modality for detection of cardiac allograft vasculopathy, dobutamine stress echocardiography has been recently frequently used as an alternative. Our aim was to evaluate the diagnostic performance of dobutamine stress echocardiography for detection of cardiac allograft vasculopathy in transplant patients.

Methods: A retrospective analysis was conducted using a total of 150 dobutamine stress echocardiographic exams that were performed on 99 patients in our institution, with paired coronary angiogram and no acute rejection, within a median of 538 [interquartile range 371-816] days. Sensitivity and specificity of dobutamine echocardiography to detect allograft vasculopathy was evaluated. Allograft vasculopathy was defined as Grade 1 or higher based on ISHLT criteria. A positive dobutamine stress echo result was defined by new or worsening wall motion abnormality.

Results: Median age of the population at transplant was 34 [interquartile range 22-46] years; 76 (77%) patients were male. Allograft vasculopathy was present in 31 (20.6%) out of 150 coronary angiograms. Only 7 (4.6%) of that number were positive on dobutamine stress echocardiography. Sensitivity and specificity for allograft vasculopathy detection was 3% and 94%, respectively. Out of 7 false positive dobutamine stress echocardiograms, two were in patients with myocardial bridging. Two patients with mild acute rejection had both negative dobutamine stress echo.

Conclusions: Overall, positivity of dobutamine stress echocardiography in patients after heart transplant is low. It has high specificity, but very low sensitivity for detection of cardiac allograft vasculopathy. Dobutamine stress echocardiography should only be cautiously used as an alternative to coronary angiography.

目的:同种异体心脏移植物血管病变是原位心脏移植术后移植物晚期衰竭和死亡的主要原因之一。尽管有创冠状动脉造影是检测同种异体移植心脏血管病变的金标准方式,多巴酚丁胺应激超声心动图最近已被频繁用作替代方法。我们的目的是评估多巴酚丁胺应激超声心动图对移植患者同种异体心脏血管病变的诊断性能。方法:对我院99例患者进行150次多巴酚丁胺应激超声心动图检查进行回顾性分析,其中有冠状动脉造影,无急性排斥反应,中位数为538天[四分位数间距371-816]。评价多巴酚丁胺超声心动图检测同种异体移植血管病变的敏感性和特异性。同种异体移植血管病变根据ISHLT标准定义为1级或以上。多巴酚丁胺应激回声阳性定义为新的或恶化的壁运动异常。结果:移植人群的中位年龄为34岁[四分位数范围22-46岁];男性76例(77%)。150例冠状动脉造影中有31例(20.6%)出现同种异体血管病变。其中只有7人(4.6%)的多巴酚丁胺应激超声心动图呈阳性。同种异体血管病变检测的敏感性和特异性分别为3%和94%。在7例多巴酚丁胺应激超声心动图假阳性中,2例为心肌桥接患者。2例轻度急性排斥反应患者多巴酚丁胺应激回声均为阴性。结论:总体而言,心脏移植术后患者多巴酚丁胺应激超声心动图阳性率较低。它对同种异体心脏移植血管病变的检测特异性高,但灵敏度很低。多巴酚丁胺应激超声心动图只能谨慎地用作冠状动脉造影的替代方法。
{"title":"Diagnostic Accuracy of Dobutamine Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Patients.","authors":"Mohammed Mahmoodurrahman,&nbsp;Josef Marek,&nbsp;Hamzah Ruxshan Juhardeen,&nbsp;Talal Al Otaibi,&nbsp;Vera Maria Cury Salemi,&nbsp;Najmeddine Echahidi,&nbsp;Jehad Al Buraiki,&nbsp;Bahaa M Fadel,&nbsp;Dania Mohty","doi":"10.37616/2212-5043.1265","DOIUrl":"https://doi.org/10.37616/2212-5043.1265","url":null,"abstract":"<p><strong>Objective: </strong>Cardiac allograft vasculopathy is one of the leading causes of late graft failure and subsequent death in orthotopic heart transplant. Although invasive coronary angiography is the gold standard modality for detection of cardiac allograft vasculopathy, dobutamine stress echocardiography has been recently frequently used as an alternative. Our aim was to evaluate the diagnostic performance of dobutamine stress echocardiography for detection of cardiac allograft vasculopathy in transplant patients.</p><p><strong>Methods: </strong>A retrospective analysis was conducted using a total of 150 dobutamine stress echocardiographic exams that were performed on 99 patients in our institution, with paired coronary angiogram and no acute rejection, within a median of 538 [interquartile range 371-816] days. Sensitivity and specificity of dobutamine echocardiography to detect allograft vasculopathy was evaluated. Allograft vasculopathy was defined as Grade 1 or higher based on ISHLT criteria. A positive dobutamine stress echo result was defined by new or worsening wall motion abnormality.</p><p><strong>Results: </strong>Median age of the population at transplant was 34 [interquartile range 22-46] years; 76 (77%) patients were male. Allograft vasculopathy was present in 31 (20.6%) out of 150 coronary angiograms. Only 7 (4.6%) of that number were positive on dobutamine stress echocardiography. Sensitivity and specificity for allograft vasculopathy detection was 3% and 94%, respectively. Out of 7 false positive dobutamine stress echocardiograms, two were in patients with myocardial bridging. Two patients with mild acute rejection had both negative dobutamine stress echo.</p><p><strong>Conclusions: </strong>Overall, positivity of dobutamine stress echocardiography in patients after heart transplant is low. It has high specificity, but very low sensitivity for detection of cardiac allograft vasculopathy. Dobutamine stress echocardiography should only be cautiously used as an alternative to coronary angiography.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"279-283"},"PeriodicalIF":0.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/79/sha-33-4-279.PMC8754441.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Radiolucent Mechanical Valve: Chest Radiography Conundrum. 透光机械瓣膜:胸片难题。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1270
Mohamad S Alabdaljabar, Genya Turgul, Adelaide M Arruda-Olson, Jeffrey B Geske
{"title":"Radiolucent Mechanical Valve: Chest Radiography Conundrum.","authors":"Mohamad S Alabdaljabar,&nbsp;Genya Turgul,&nbsp;Adelaide M Arruda-Olson,&nbsp;Jeffrey B Geske","doi":"10.37616/2212-5043.1270","DOIUrl":"https://doi.org/10.37616/2212-5043.1270","url":null,"abstract":"","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"294-295"},"PeriodicalIF":0.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/88/sha-33-4-294.PMC8754442.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simultaneous Bicarotid and Microscope-assisted Coronary Revascularization as an Individual Surgical Strategy. 同时颈动脉和显微镜辅助冠状动脉血管重建术作为一种单独的手术策略。
IF 0.8 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.37616/2212-5043.1273
Andrey N Semchenko

A 59-year-old man presented with complaints of giddiness caused by changes in body position, unsteady gait, daily episodes of vision loss, breathlessness, and chest pain flowing minor physical exertion. Computed tomography revealed occlusion of the right common carotid artery, critical stenosis of the left common carotid artery, and significant stenosis of the left internal carotid artery. A coronarography detected stenosis of the left main coronary artery plus 3-vessel disease. Simultaneous aortic-bicarotid bifurcation prosthesis and coronary artery bypass grafting were performed. The patient showed a satisfactory postoperative outcome.

59岁男性,主诉体位改变、步态不稳、每日视力丧失、呼吸困难和轻微体力消耗引起的胸痛。计算机断层扫描显示右侧颈总动脉闭塞,左侧颈总动脉严重狭窄,左侧颈内动脉明显狭窄。冠状动脉造影发现左冠状动脉主干狭窄合并三支血管病变。同时行主动脉-颈动脉分叉假体和冠状动脉旁路移植术。患者术后表现满意。
{"title":"Simultaneous Bicarotid and Microscope-assisted Coronary Revascularization as an Individual Surgical Strategy.","authors":"Andrey N Semchenko","doi":"10.37616/2212-5043.1273","DOIUrl":"https://doi.org/10.37616/2212-5043.1273","url":null,"abstract":"<p><p>A 59-year-old man presented with complaints of giddiness caused by changes in body position, unsteady gait, daily episodes of vision loss, breathlessness, and chest pain flowing minor physical exertion. Computed tomography revealed occlusion of the right common carotid artery, critical stenosis of the left common carotid artery, and significant stenosis of the left internal carotid artery. A coronarography detected stenosis of the left main coronary artery plus 3-vessel disease. Simultaneous aortic-bicarotid bifurcation prosthesis and coronary artery bypass grafting were performed. The patient showed a satisfactory postoperative outcome.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"33 4","pages":"267-270"},"PeriodicalIF":0.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b6/25/sha-33-4-267.PMC8754436.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39963943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Saudi Heart Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1